Viewing Study NCT06538935


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-02-19 @ 7:47 AM
Study NCT ID: NCT06538935
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-06
First Post: 2024-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma
Sponsor: Fujian Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module